RxDoctor Payments Data

Michael Brennan, MD

Physical Medicine & Rehabilitation · Fairfield, CTNPI 1538117049

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $11,605 of the $19,026 with a category attached, or 61.0%. 34 manufacturers reported payments, led by Biodelivery Sciences International, Inc. at 24.1% of the total. Reporting peaked in 2021 at $10,240 and has fallen 97.9% since, to $216 in 2024. Among physical medicine & rehabilitation clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,026in general payments, 2019–2025

Across 443 payments — averaging $42.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biodelivery Sciences International, Inc.$5K
  • Redhill Biopharma Inc.$4K
  • Scilex Pharmaceuticals Inc.$4K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • Collegium Pharmaceutical, Inc.$1K
  • Purdue Pharma L.p.$1K
  • plus $3K from 28 others

What the payments were for

  • Consulting fees$1,0005%
  • Speaking & faculty fees$11,60561%
  • Food & beverage$6,32833%
  • Education$930%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,026 in reported general payments places this provider in the 95th percentile of 107 physical medicine & rehabilitation providers in Connecticut.

See all physical medicine & rehabilitation providers in Connecticut

Medicare billing

Part B allowed, 2024
$34,804
Medicare patients
93
Services billed
454

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl215$230,109
Xtampza ErOxycodone Myristate115$118,638
NucyntaTapentadol Hcl35$55,953
Oxycodone Hcl974$33,593
ZtlidoLidocaine18$16,442
Fentanyl104$14,444
Oxymorphone Hcl ErOxymorphone Hcl14$12,549
MovantikNaloxegol Oxalate21$11,605
Morphine Sulfate147$6,370
Morphine Sulfate ErMorphine Sulfate163$6,189
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl16$5,119
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen128$4,196
Hydromorphone ErHydromorphone Hcl17$3,995
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen113$3,846
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine17$3,206

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Purdue Pharma L.p.Oxycontin$1,000$230,109215 claims
Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta$1,084$174,592150 claims
Scilex Pharmaceuticals Inc.Ztlido$3,792$16,44218 claims
Redhill Biopharma Inc.Movantik$4,295$11,60521 claims
Hikma Pharmaceuticals USAMorphine Sulfate, Buprenorphine-Naloxone$34$11,489163 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 107 physical medicine & rehabilitation providers in Connecticut.

Other physical medicine & rehabilitation in Fairfield

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →